How I approach pharmacological thromboprophylaxis in children

Area of Science:

• Pediatric Hematology
• Clinical Pharmacology
• Evidence-Based Medicine

Background:

• Pediatric venous thromboembolism (VTE) incidence has significantly increased over the past two decades.
• Existing VTE risk models and prevention trials exist, but comprehensive guidelines for thromboprophylaxis (TP) in diverse pediatric populations are lacking.
• Risk-stratified approaches considering both VTE and bleeding risks are crucial for pharmacological TP in hospitalized children.

Purpose of the Study:

• To present a pragmatic, evidence-informed approach to pharmacological thromboprophylaxis (TP) for hospitalized children.
• To review existing VTE risk models and TP clinical trial data in pediatric populations.
• To address knowledge gaps and propose future research directions for pediatric VTE prevention.

Main Methods:

• Review of existing literature on pediatric VTE risk prediction models.
• Analysis of data from multicenter randomized clinical trials on thromboembolism prevention in children.
• Development of a pragmatic, risk-stratified TP approach for common inpatient scenarios.
• Case-based review of clinical scenarios to illustrate TP strategies.

Main Results:

• Identification of a lack of comprehensive guidelines for pediatric thromboprophylaxis across various at-risk subpopulations and settings.
• Emphasis on the need for risk-stratified pharmacological TP based on a priori VTE and bleeding risks.
• Presentation of evidence-based, pragmatic TP recommendations for specific inpatient scenarios.

Conclusions:

• A risk-stratified, subpopulation- and setting-specific approach to pharmacological thromboprophylaxis is essential for hospitalized children.
• Further research is needed to address critical knowledge gaps in pediatric VTE prevention.
• Future trials should focus on informing evidence-based TP strategies for diverse pediatric populations.